Evidence map›Paper›PMID 31463046›Full record

ArticleAntimicrobial resistance and infection control2019

Antimicrobial susceptibility and molecular characteristics of

Fei Zhao, Jing Li, Jinrong Liu, Xuemei Guan, Jie Gong, Liyong Liu, Lihua He, Fanliang Meng, Jianzhong Zhang

Abstract readMulticenter Study
In one paragraph

Article in Antimicrobial resistance and infection control, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Machine learning-based prediction models for severeFrontiers in public health · 2026
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Antimicrobial Susceptibility and Distribution Characteristics ofPharmaceuticals (Basel, Switzerland) · 2026
    Article
  8. Review
  9. Article
  10. Macrolide-resistantFrontiers in pediatrics · 2026
    Article
  11. Genomic epidemiology and antimicrobial susceptibility of clinicalFrontiers in cellular and infection microbiology · 2026
    Article
  12. Observational
  13. Article
  14. Macrolide-ResistantMicroorganisms · 2025
    Article
  15. Article
  16. Antimicrobial activity of lefamulin against pathogens most commonly causing community-acquired pneumonia: results from the China antimicrobial surveillance network in 2020-2022.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  17. JAC-antimicrobial resistance · 2025
    Article
  18. Article
  19. Genetic factors driving theThe Lancet regional health. Western Pacific · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fei Zhao *1National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory of Infectious Disease Prevention and Control, 155 Changbai Road, Changping District, Beijing, 102206 China.
Jing Li *2Office of Laboratory Management, Chinese Center for Disease Control and Prevention, Beijing, 102206 China.
Jinrong Liu3Department of Respiratory Medicine, Beijing Children's Hospital, National Center for Children's Health, Capital Medical University, Nanlishi Road 56, Xicheng District, Beijing, China.
Xuemei Guan4Affiliated Hospital of Beihua University, Jilin, 132011 China.
Jie Gong1National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory of Infectious Disease Prevention and Control, 155 Changbai Road, Changping District, Beijing, 102206 China.
Liyong Liu1National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory of Infectious Disease Prevention and Control, 155 Changbai Road, Changping District, Beijing, 102206 China.
Lihua He1National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory of Infectious Disease Prevention and Control, 155 Changbai Road, Changping District, Beijing, 102206 China.
Fanliang Meng1National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory of Infectious Disease Prevention and Control, 155 Changbai Road, Changping District, Beijing, 102206 China.
Jianzhong Zhang1National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, State Key Laboratory of Infectious Disease Prevention and Control, 155 Changbai Road, Changping District, Beijing, 102206 China.ORCID 0000-0001-7056-8206

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: In China mainland, most Methods: Genotyping was performed to 154 Results: Genotype I was detected in 118 Conclusions: A large variance was identified in the

Indexed as

Drug Resistance, BacterialAzithromycinChinaDNA, RibosomalErythromycinGenotypeGenotyping TechniquesHumansMicrobial Sensitivity TestsMinisatellite RepeatsMultilocus Sequence TypingMycoplasma pneumoniaePneumonia, MycoplasmaRNA, Ribosomal, 23SSequence Analysis, DNAAzithromycinDNA, RibosomalErythromycinRNA, Ribosomal, 23S23S rRNA geneGenotypeMacrolide resistanceMycoplasma pneumoniae

Identifiers

PMID31463046
PMCPMC6708159

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.